Self-Image Profile in Children and Adolescents with Attention Deficit/ Hyperactivity Disorder and the Quality of Life in Their Parents

2015 ◽  
Vol 49 (1) ◽  
pp. 19-33 ◽  
Author(s):  
Vahdet Gormez ◽  
Fiona C. M. Forbes
2022 ◽  
Vol 40 ◽  
Author(s):  
Marcone de Souza Oliveira ◽  
Mayke Felipe Dias Marinho ◽  
Stela Maris Aguiar Lemos

Abstract Objective: To identify associations between clinical characteristics of children with attention-deficit/hyperactivity disorder (ADHD) and their sociodemographic aspects, quality of life, and results from the strengths and difficulties questionnaire. Methods: This is an observational analytical cross-sectional study with a non-probabilistic sample consisting of 72 children diagnosed with ADHD, aged 6 to 13 years, treated at 2 neuropediatric outpatient clinics. The instruments used were the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder – Swanson, Nolan, and Pelham, version IV (MTA-SNAP-IV), the Strengths and Difficulties Questionnaire (SDQ), the Brazilian Economic Classification Criteria (CCEB), and the Quality of Life Assessment Scale for Children and Adolescents (AUQEI). We performed descriptive, bivariate, and multivariate analyses, considering a 5% significance level. Results: SDQ results were associated with abnormal MTA-SNAP-IV results (inattentive/hyperactive/combined). A 1-point increment in the SDQ score increased by 36.5% the likelihood of the child having an abnormal MTA-SNAP-IV classification. Regarding AUQEI, 30.6% of participants perceived their quality of life as poor and 69.4% as good. Conclusions: A higher SDQ score increased the child's chance of having an abnormal MTA-SNAP-IV result.


2020 ◽  
Vol 26 (Suppl. 4-5) ◽  
pp. 274-282 ◽  
Author(s):  
Fabio Lugoboni ◽  
Anna Bertoldi ◽  
Rebecca Casari ◽  
Elisa Mantovani ◽  
Laura Morbioli ◽  
...  

2009 ◽  
Vol 19 (2) ◽  
pp. 83-105 ◽  
Author(s):  
Marina Danckaerts ◽  
Edmund J. S. Sonuga-Barke ◽  
Tobias Banaschewski ◽  
Jan Buitelaar ◽  
Manfred Döpfner ◽  
...  

2012 ◽  
Vol 5 ◽  
pp. JCNSD.S6691 ◽  
Author(s):  
Anna C. Shier ◽  
Thomas Reichenbacher ◽  
Harinder S. Ghuman ◽  
Jaswinder K. Ghuman

Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of childhood that can result in significant functional impairment, and if not adequately treated can lead to impaired quality of life. Pharmacotherapy is considered the first-line treatment for ADHD in children and adolescents. We review both recent literature and seminal studies regarding the pharmacological treatment of ADHD in children and adolescents. There is ample evidence for the efficacy and safety of both stimulants and non-stimulants in the treatment of ADHD. We review important aspects of evaluation and assessment and discuss first-line pharmacological treatments and as well as when to consider using alternative pharmacological agents. Treatment approaches to manage frequently seen comorbid disorders with ADHD are also covered.


Sign in / Sign up

Export Citation Format

Share Document